Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: The latest comparative study to intestinal advanced gastric cancer

Hepato-Gastroenterology

Volumn 56, Issue 89, 2009, Pages 276-281

  Yamashita, K ^a   Sakuramoto, S ^a   Katada, N ^a   Futawatari, N ^a   Moriya, H ^a   Hirai, K ^a   Kikuchi, S ^a   Watanabe, Masahiko ^a  

^a KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Advanced gastric cancer; Depth of invasion; Diffuse type; Peritoneal free cancer cell; Prognosis

Indexed keywords

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; ARTICLE; CANCER CELL; CANCER INVASION; CANCER STAGING; CHINA; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; DISTANT METASTASIS; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CANCER; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; PERITONEUM CANCER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; STOMACH CANCER; UNIVERSITY HOSPITAL;

AGE FACTORS; AGED; FEMALE; GASTRECTOMY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 64949201263     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lauren P: The two histologic main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta. Pathol. Microbiol. Scand. 1965; 64:31-49.
2. Ming SC: Gastric carcinoma: a pathobiological classification. Cancer 1977; 39:2475-2485.
3. Sugano H., Nakamura K., Y.K.: Pathological studies of human gastric cancer. Act. Pathol. Jpn. 1982; 32:329-347.
4. Noda S., Soejima K., K.I: Clinicopathological analysis of the intestinal type and diffuse type of gastric carcinoma. Jpn. J. Surg. 1980; 10:277-283.
5. Adachi Y., Yasuda K., Inomata M., Sato K., Shiraishi N., S.K: Pathology and Prognosis of Gastric Carcinoma. Well Versus Poorly Differentiated Type. Cancer 2000; 89:1418-1424.
6. Riberio MM., Sarmento JA, Simoes MAS, J.B: Prognostic singiifcance of Lauren and Ming classification and other pathologica parameters and histoloigic classification. Cancer 1981; 47:780-784.
7. Davessar K, Pezzullo JC, Simoes MAS, J.B.: Gastric adenocarcinoma: prognostic significance of several pathologic parameters and histologic classification. Hum. Pahol. 1990; 21:325-332.
8. Stemmermann GN, C B.: A survival study of intestinal and diffuse types of gastric carcinoma. Cancer 1974; 33:1190-1195.
9. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma. (English version). 1999; The 13 th edition.
10. Kaplan EL, PM.: Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958; 53:457-481.
11. Cox DR.: Regression models and life-tables. J. R. Stat. Soc. (B) 1972; 34:187-220.
12. Moriguchi S, Kamakura T, Odaka T, et al.: Clinical features of the differentiated and undifferentiated types of advanced gastric carcinoma: univariate and multivariate analyses. J Surg Oncol. 1991; 48:202-206.
13. Adachi Y, Suematsu T, Yasuda K, Shiromizu A, Shiraishi N, Kitano S.: Clinicopathologic study of gastric cancer based on Dukes' classification. World J Surg. 1999; 23:499-502.
14. Kobayashi M, Nagata S, Iwasaki T, et al.: Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A. 1999; 96:4874-4879.
15. Linghu H, Tsuda M, Makino Y, et al.: Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS. Oncogene. 2006; 25:3547-3556.
16. Kobayashi M, Iwamatsu A, Shinohara-Kanda A, Ihara S, Fukui Y.: Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas. Oncogene. 2003; 22:1294-1301.
17. Nakanishi H, Kodera Y, Torii A, et al: Detection of carcinoembryonic antigen-expressing free tumor cells in peritoneal washes from patients with gastric carcinoma by polymerase chain reaction. Jpn J Cancer Res. 1997; 88: 687-692.
18. Kodera Y, Nakanishi H, Yamamura Y, et al.: Prognostic value and clinical implications of disseminated cancer cells in the peritoneal cavity detected by reverse transcriptase-polymerase chain reaction and cytology. Int J Cancer. 1998; 79:429-433.
19. Kodera Y, Nakanishi H, Ito S, et al: Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction: a sensitive predictor of outcome for patients with gastric carcinoma. Ann Surg. 2002; 235:499-506.
20. Ito S, Nakanishi H, Kodera Y, Mochizuki Y, Tatematsu M, Yamamura Y: Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients. Br J Cancer. 2005; 93:986-992.
21. Mutsaers SE, Wilkosz S.: Structure and function of mesothelial cells. Cancer Treat Res. 2007; 134:1-19.
22. Yamashita K., Sakuramoto S., Kikuchi S., Katada N., Kobayashi N., M.W.: Strong Association of Lymph Node Metastasis with Intraperitoneal Free Cancer Cell (IFCC) in Advanced Gastric Cancer. Hepato-gastroenterology in press.
23. Tanaka T, Kumagai K, Shimizu K, Masuo K, K Y.: Peritoneal metastasis in gastric cancer with particular reference to lymphatic advancement; extranodal invasion is a significant risk factor for peritoneal metastasis. J. Surg. Oncol. 2000; 75:165-171.